HIGHLIGHTS
- who: Lingfei Zhao from the Zhejiang University, Hangzhou, People’s Republic of China have published the research: Induction therapy with mesenchymal stromal cells in kidney transplantation: a meta-analysis, in the Journal: (JOURNAL)
- what: The aim of this meta-analysis was to evaluate the therapeutic effects of mesenchymal stromal cells (MSCs) versus traditional regimens for induction therapy in kidney transplantation (KT) especially the safety of MSC infusion practicability of MSCs as induction therapy agents and posttransplant complications. Based on the functions of MSCs, the main reason MSCs were introduced as an induction therapy was to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.